Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
Journal of Neuro-Oncology
|
January 29, 2014
CSF CA 15-3 in breast cancer-related leptomeningeal metastases
Emilie Le Rhun, Andrew Kramar, Sophie Salingue, et al.
Blood
|
April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report
Sigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Journal of Neuro-Oncology
|
December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study
Manmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.
Neuro-Oncology
|
April 24, 2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L Albert, Michael Weller, Bogdana Suchorska, et al.
Neuro-Oncology Advances
|
October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
Priya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma
Wolfgang Wick, Vinay K Puduvalli, Marc C Chamberlain, et al.
Neuro-Oncology
|
March 5, 2008
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies
Morris D Groves, Michael J Glantz, Marc C Chamberlain, et al.
Neuro-Oncology
|
May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group
Nils D Arvold, Terri S Armstrong, Katherine E Warren, et al.
Neuro-Oncology
|
April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee
Katherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Neuro-Oncology
|
February 12, 2011
Clinical trial end points for high-grade glioma: the evolving landscape
David A Reardon, Evanthia Galanis, John F DeGroot, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
Journal of Neuro-Oncology
|
January 29, 2014
CSF CA 15-3 in breast cancer-related leptomeningeal metastases
Emilie Le Rhun, Andrew Kramar, Sophie Salingue, et al.
Blood
|
April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report
Sigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Journal of Neuro-Oncology
|
December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study
Manmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.
Neuro-Oncology
|
April 24, 2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L Albert, Michael Weller, Bogdana Suchorska, et al.
Neuro-Oncology Advances
|
October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
Priya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma
Wolfgang Wick, Vinay K Puduvalli, Marc C Chamberlain, et al.
Neuro-Oncology
|
March 5, 2008
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies
Morris D Groves, Michael J Glantz, Marc C Chamberlain, et al.
Neuro-Oncology
|
May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group
Nils D Arvold, Terri S Armstrong, Katherine E Warren, et al.
Neuro-Oncology
|
April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee
Katherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Neuro-Oncology
|
February 12, 2011
Clinical trial end points for high-grade glioma: the evolving landscape
David A Reardon, Evanthia Galanis, John F DeGroot, et al.
Page
of 17